SeaStar Medical ($ICU): Can the Stock Reach the $8.00 Analyst Target? (Check any stock’s price target on Tickeron.) The $8.00 target is the most widely cited public price objective for ICU, originating from a single named analyst at Maxim Group, not a multi-an

SeaStar Medical ($ICU): Can the Stock Reach the $8.00 Analyst Target? (Check any stock’s price target on Tickeron.) The $8.00 target is the most widely cited public price objective for ICU, originating from a single named analyst at Maxim Group, not a multi-analyst consensus. ICU's analyst coverage is thin; the one current, attributable target is $8.00, set on May 14, 2026. At a recent close near $4.69, reaching $8.00 implies a gain of roughly 70%, a very large move. Supporting factors include accelerating QUELIMMUNE adoption, high gross margins, and the adult NEUTRALIZE-AKI pivotal trial. Key risks include heavy share dilution, ongoing operating losses, a small cash balance, and reliance on a single commercial product. $CANF $APVO $GNPX $TNXP $LONA